Calendar Provectus Biopharmaceuticals, Inc. OTC Bulletin Board

Equities

PVCT

US74373P1084

End-of-day quote OTC Bulletin Board 5-day change 1st Jan Change
- USD -.--% Intraday chart for Provectus Biopharmaceuticals, Inc. -.--% -.--%

Chart calendar Provectus Biopharmaceuticals, Inc.

5be.QifqR99RvSPHQk1FcSp5RVlDAgTUdrBgx10E_rOO2xQ.cWurd6ULiXuzOhkqLnoNMRUmUWm4KdYsiBJhpob6iFULRoQ0tgXPF7F6Ig~d53f8eae4ce8eb8d3957eec34cf6c4ca

Upcoming events on Provectus Biopharmaceuticals, Inc.

14/05/2024 Society for Investigative Dermatology Meeting

Past events on Provectus Biopharmaceuticals, Inc.

04/04/2024 American Association for Cancer Research Meeting
22/02/2024 20:00 Business Update Call
05/11/2023 Society for Melanoma Research Congress - Combination PV-10 autolytic immunotherapy
05/11/2023 Society for Melanoma Research Congress - Percutaneous autolytic immunotherapy
31/10/2023 Society for Immunotherapy of Cancer Meeting
30/11/2022 Melanoma Bridge Conference
22/06/2022 21:00 Annual Genral Meeting
16/06/2022 International Society of Ocular Oncology Congress
06/06/2022 19:15 American Society of Clinical Oncology Meeting - Abstract No 9543
07/04/2022 American Association of Cancer Research Meeting - Abstract No 2720
09/03/2022 European Neuroendocrine Tumor Society Conference - Abstract No: 3455, I25
27/10/2021 Society for Melanoma Research Meeting - Cutaneous Melanoma
27/10/2021 Society for Melanoma Research Congress - Checkpoint Blockade
15/09/2021 ESMO Congress Conference - Abstract No - 4354
23/06/2021 21:00 Annual Genral Meeting
08/11/2020 Society of Immunotherapy of Cancer Meeting - Abstract Number : 585
18/09/2020 European Society for Medical Oncology Virtual Congress - Poster No -4397
18/09/2020 European Society for Medical Oncology Virtual Congress - Poster No -4281
21/06/2020 American Association for Cancer Research Virtual Meeting - Abstract number: 5393
28/05/2020 American Society of Clinical Oncology Virtual Annual Meeting - Abstract No - 1
  1. Stock Market
  2. Equities
  3. PVCT Stock
  4. PVCT Stock
  5. Calendar Provectus Biopharmaceuticals, Inc.